A potential anti-amyloidogenic therapy for type 2 diabetes based on the QBP1 peptide
María M. Tejero-Ojeda, Ada Bernaus Vives, Michał Wojciechowski, Dinh Quoc Huy Pham, Mateusz Chwastyk, Mario Vallejo, Anna Novials, Mariano Carrión‐Vázquez
This paper demonstrates that the QBP1 peptide effectively inhibits hIAPP aggregation and protects β-cells from amyloid-induced toxicity in vitro.
bioRxiv · May 6, 2025 · PreprintBiochemistry